↓ Skip to main content

Heme iron polypeptide for the treatment of iron deficiency anemia in non-dialysis chronic kidney disease patients: a randomized controlled trial

Overview of attention for article published in BMC Nephrology, March 2013
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (67th percentile)

Mentioned by

twitter
5 tweeters

Citations

dimensions_citation
26 Dimensions

Readers on

mendeley
65 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Heme iron polypeptide for the treatment of iron deficiency anemia in non-dialysis chronic kidney disease patients: a randomized controlled trial
Published in
BMC Nephrology, March 2013
DOI 10.1186/1471-2369-14-64
Pubmed ID
Authors

Shankar P Nagaraju, Adam Cohn, Ayub Akbari, Janet L Davis, Deborah L Zimmerman

Abstract

Anemia secondary to iron deficiency is common in patients with non-dialysis dependent chronic kidney disease (ND-CKD) but it is unclear if oral supplementation is as effective as intravenous (IV) supplementation in re-establishing iron stores. The purpose of this study was to determine if oral Heme Iron Polypeptide (HIP) is as effective as IV iron sucrose in the treatment of iron-deficiency anemia for patients with ND-CKD.

Twitter Demographics

The data shown below were collected from the profiles of 5 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 65 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 65 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 10 15%
Other 7 11%
Researcher 7 11%
Student > Ph. D. Student 5 8%
Student > Doctoral Student 5 8%
Other 16 25%
Unknown 15 23%
Readers by discipline Count As %
Medicine and Dentistry 30 46%
Agricultural and Biological Sciences 5 8%
Pharmacology, Toxicology and Pharmaceutical Science 4 6%
Nursing and Health Professions 2 3%
Biochemistry, Genetics and Molecular Biology 2 3%
Other 6 9%
Unknown 16 25%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 April 2021.
All research outputs
#6,496,578
of 20,653,890 outputs
Outputs from BMC Nephrology
#707
of 2,263 outputs
Outputs of similar age
#53,553
of 171,443 outputs
Outputs of similar age from BMC Nephrology
#1
of 1 outputs
Altmetric has tracked 20,653,890 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 2,263 research outputs from this source. They receive a mean Attention Score of 4.3. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 171,443 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them